Histiocytic sarcoma after acute lymphoblastic leukaemia

A common clonal origin

Andrew L. Feldman, Caterina P. Minniti, Mariarita Santi, James R. Downing, Mark Raffeld, Elaine S. Jaffe

Research output: Contribution to journalArticle

69 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)248-250
Number of pages3
JournalLancet Oncology
Volume5
Issue number4
DOIs
StatePublished - Apr 1 2004
Externally publishedYes

Fingerprint

Neoplasm DNA
Antineoplastic Combined Chemotherapy Protocols
Histiocytic Sarcoma
Gene Rearrangement
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Sarcoma
Clone Cells

ASJC Scopus subject areas

  • Oncology

Cite this

Histiocytic sarcoma after acute lymphoblastic leukaemia : A common clonal origin. / Feldman, Andrew L.; Minniti, Caterina P.; Santi, Mariarita; Downing, James R.; Raffeld, Mark; Jaffe, Elaine S.

In: Lancet Oncology, Vol. 5, No. 4, 01.04.2004, p. 248-250.

Research output: Contribution to journalArticle

Feldman, Andrew L. ; Minniti, Caterina P. ; Santi, Mariarita ; Downing, James R. ; Raffeld, Mark ; Jaffe, Elaine S. / Histiocytic sarcoma after acute lymphoblastic leukaemia : A common clonal origin. In: Lancet Oncology. 2004 ; Vol. 5, No. 4. pp. 248-250.
@article{3f2249beb97b4864bf9daf333d3745ea,
title = "Histiocytic sarcoma after acute lymphoblastic leukaemia: A common clonal origin",
author = "Feldman, {Andrew L.} and Minniti, {Caterina P.} and Mariarita Santi and Downing, {James R.} and Mark Raffeld and Jaffe, {Elaine S.}",
year = "2004",
month = "4",
day = "1",
doi = "10.1016/S1470-2045(04)01428-7",
language = "English (US)",
volume = "5",
pages = "248--250",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "4",

}

TY - JOUR

T1 - Histiocytic sarcoma after acute lymphoblastic leukaemia

T2 - A common clonal origin

AU - Feldman, Andrew L.

AU - Minniti, Caterina P.

AU - Santi, Mariarita

AU - Downing, James R.

AU - Raffeld, Mark

AU - Jaffe, Elaine S.

PY - 2004/4/1

Y1 - 2004/4/1

UR - http://www.scopus.com/inward/record.url?scp=1642381064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642381064&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(04)01428-7

DO - 10.1016/S1470-2045(04)01428-7

M3 - Article

VL - 5

SP - 248

EP - 250

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 4

ER -